Evidence map›Paper›PMID 26812940›Full record

ArticleScientific reports2016

Generating trunk neural crest from human pluripotent stem cells.

Miller Huang, Matthew L Miller, Lauren K McHenry, Tina Zheng, Qiqi Zhen, Shirin Ilkhanizadeh, Bruce R Conklin, Marianne E Bronner, William A Weiss

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cell state plasticity in neuroblastoma.EJC paediatric oncology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Miller HuangDepartment of Neurology and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158 USA.
Matthew L MillerDepartment of Neurology and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158 USA.
Lauren K McHenryDepartment of Neurology and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158 USA.
Tina ZhengDepartment of Neurology and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158 USA.
Qiqi ZhenDepartment of Neurology and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158 USA.
Shirin IlkhanizadehDepartment of Neurology and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158 USA.
Bruce R ConklinGladstone Institute of Cardiovascular Disease, San Francisco, CA 94158 USA.
Marianne E BronnerDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.
William A WeissDepartment of Neurology and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158 USA.
UCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of California, San Francisco · USCalifornia Institute of Technology · USGladstone Institutes · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Leigh Clarke · 1999 to 2026
$209.7M
Progenitor Cell Biology Consortium Administrative Coordinating CenterU01HL099997 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI TERRIN, MICHAEL L · 2009 to 2015
$29.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
Transcriptional Networks During Cardiac DifferentiationP01HL089707 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI SRIVASTAVA, DEEPAK · 2008 to 2017
$20.4M
Tissue Engineering with a Modular RASSL ToolboxR01HL060664 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI CONKLIN, BRUCE R · 1998 to 2012
$7.0M
Gene Regulatory Network Controlling Premigratory Cranial vs Trunk Neural CrestR01DE024157 · NIDCR · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BRONNER, MARIANNE · 2014 to 2025
$4.0M
Murine Neuroblastoma Models for Preclinical TherapeuticsR01CA102321 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, WILLIAM A · 2003 to 2016
$3.4M
Targeting BET-bromodomains in neuroblastomaR01NS088355 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEGMAIER, KIMBERLY, WEISS, WILLIAM A · 2015 to 2019
$3.3M
Genetic network analysis of cancer targetsU01CA176287 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, WILLIAM A · 2013 to 2016
$1.2M
NCI NIH HHS P30 CA082103NCI NIH HHS P30CA82103NCI NIH HHS R01 CA102321NCI NIH HHS R01CA102321NCI NIH HHS U01 CA176287NCI NIH HHS U01U01CA176287NHLBI NIH HHS P01 HL089707NHLBI NIH HHS P01HL089707NHLBI NIH HHS R01 HL060664NHLBI NIH HHS R01HL060664NHLBI NIH HHS U01 HL099997NHLBI NIH HHS U01HL099997NIDCR NIH HHS R01 DE024157NIDCR NIH HHS R01DE024157NIGMS NIH HHS T32 GM007618NINDS NIH HHS R01 NS088355NINDS NIH HHS R01NS088355
6 · The paper itself

Abstract

Neural crest cells (NCC) are stem cells that generate different lineages, including neuroendocrine, melanocytic, cartilage, and bone. The differentiation potential of NCC varies according to the level from which cells emerge along the neural tube. For example, only anterior "cranial" NCC form craniofacial bone, whereas solely posterior "trunk" NCC contribute to sympathoadrenal cells. Importantly, the isolation of human fetal NCC carries ethical and scientific challenges, as NCC induction typically occur before pregnancy is detectable. As a result, current knowledge of NCC biology derives primarily from non-human organisms. Important differences between human and non-human NCC, such as expression of HNK1 in human but not mouse NCC, suggest a need to study human NCC directly. Here, we demonstrate that current protocols to differentiate human pluripotent stem cells (PSC) to NCC are biased toward cranial NCC. Addition of retinoic acid drove trunk-related markers and HOX genes characteristic of a posterior identity. Subsequent treatment with bone morphogenetic proteins (BMPs) enhanced differentiation to sympathoadrenal cells. Our approach provides methodology for detailed studies of human NCC, and clarifies roles for retinoids and BMPs in the differentiation of human PSC to trunk NCC and to sympathoadrenal lineages.

Indexed as

Cell DifferentiationBiomarkersBone Morphogenetic ProteinsCells, CulturedGene Expression Regulation, DevelopmentalHomeodomain ProteinsHumansNeural CrestPluripotent Stem CellsSignal TransductionTretinoinBiomarkersBone Morphogenetic ProteinsHomeodomain ProteinsTretinoin

Identifiers

PMID26812940
PMCPMC4728437
OpenAlexW2254866812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.